
USA Health researchers and clinicians are experts in their fields, making them trusted sources on many health-related topics in the news.
We want to show you that what you do at work has a purpose and is ultimately bettering the lives of the people around you, the overall health system and the community.
USA Health Insider is a weekly newsletter featuring news and insights for employees of USA Health as we fulfill our mission to help people lead longer, better lives. Please submit your story ideas to Carol McPhail at [email protected]
USA Health researchers and clinicians are experts in their fields, making them trusted sources on many health-related topics in the news.
The Teaching Kitchen Collaborative is an invitational network of organizations using teaching kitchen facilities and concepts to promote personal and public health.
December specials for employees include discounts on skin treatments and microneedling for those on your holiday shopping list.
Each week, we capture images from construction, expansion and renovations occurring across USA Health.
James Jewell brings experience from the Federal Bureau of Investigation, where he served for 25 years, most recently as special agent in charge of the Mobile Division.
Physician-scientist Jennifer M. Scalici, M.D., has been named the recipient of the 2021 Mayer Mitchell Award for Excellence in Cancer Research.
Donations are needed to help USA Health employees who have requested assistance through the Emergency PTO Program.
USA Health researchers and clinicians are experts in their fields, making them trusted sources on many health-related topics in the news.
December specials for employees include discounts on skin treatments and microneedling for those on your holiday shopping list.
USA Health regularly recognizes employees for going above and beyond in their care of patients and customer service.
Each week, we capture images from construction, expansion and renovations occurring across USA Health.
Molecular profiling is becoming a critical tool in identifying genomic mutations that indicate a potential response to targeted cancer therapy.